We're on a mission to revolutionize breast imaging.

About QTbreasthealth

QTbreasthealth brings to market an evolution in breast imaging.  Our imaging centers offer the new FDA-cleared QTscan, which provides exceptional breast imaging clarity and quality with no harmful radiation and no painful compression. It’s safe, easy, and part of a unique patient-centric experience that includes comfort, compassion, and confidence in the results.

Each year, approximately 39 million women, in the United States, get mammograms. For every 1 woman with cancer, 19 more will be told they might have cancer when they don’t. The cost, time, and psychological distress take an enormous toll. QT Ultrasound exists to change the paradigm of breast imaging and to keep women from going through the trauma of this journey.

The Leadership of QTbreasthealth

Margaret Donigan
PRESIDENT
Margaret Donigan
PRESIDENT

Margaret Donigan leads the QTbreasthealth team as well as serving as the Chief Strategy Officer of QT Ultrasound. Prior to joining QT Ultrasound, she spent more than a decade in middle market private equity, leading strategy development and making principal investments in more than a dozen companies, covering a variety of industries including healthcare. Ms. Donigan served as Executive Vice President of Corporate Development at Paradigm Tax Group, a company for which she led the recapitalization and served on the Board. She received her B.A. from Yale University and earned her M.B.A. in Finance and Operations Management from the Wharton School at the University of Pennsylvania, where she graduated as a Palmer Scholar.

Dotty J. Bollinger
BUSINESS DEVELOPMENT
Dotty J. Bollinger
BUSINESS DEVELOPMENT

Dotty Bollinger brings over 30 years of healthcare industry experience, leading commercialization efforts and providing growth strategies and services to high-profile and high-impact healthcare clients, to her role at QTbreasthealth. Most recently, Ms. Bollinger was an operating partner for GPB Capital, a New York-based alternative asset management firm, where she oversaw the company’s healthcare vertical. In her role there, she led evaluations of prospective healthcare company acquisitions as well as their integration into the overall healthcare portfolio.

Ms. Bollinger previously served as President and Chief Operating Officer of a national minimally invasive spine surgery center, where she was responsible for overseeing all corporate and medical operations.

Her experience has resulted in awards and distinctions from Modern Healthcare, Becker's ASC Review, and the Tampa Bay Business Journal, among others. She has also authored two books that provide practical guidance for like-minded women and often serves as a mentor for aspiring female leaders.

A graduate of Maria College in Albany, New York, Ms. Bollinger obtained her nursing degree in 1986 and later completed her bachelor's degree in Management and Marketing at the University of Maryland University College. She subsequently earned a law degree from the University of South Dakota School of Law.

Allie Talbot
SENIOR MANAGER OF INFORMATION CENTER
Allie Talbot
SENIOR MANAGER OF INFORMATION CENTER

Allie Talbot is the Senior Manager, Information Center at QTbreasthealth. Through leadership of the organization's Information Center, Ms. Talbot ensures every guest receives an optimal experience, from the first point of contact through post-appointment follow-ups. She also develops, manages and oversees the organization's passionate guest advocates.

Ms. Talbot is a skilled customer service professional with healthcare leadership experience. Most recently, she was the Manager of Customer Care at Laser Spine Institute, where she was responsible for leading a team of 48 Customer Care Representatives. She came to QTbreasthealth because of the impact the organization is making on women and is excited to be part of the evolution in breast imaging.

The native Floridian received her associate degree from Valencia Community College in Orlando before graduating Magna Cum Laude with a bachelor’s degree from Florida State University.

Rachel Johnson
REGIONAL OPERATIONS MANAGER
Rachel Johnson
REGIONAL OPERATIONS MANAGER

Rachel Johnson is the Regional Operations Manager at QTbreasthealth. In her role, Ms. Johnson is responsible for overseeing all clinical operations to ensure that consistency, standardization and quality of care meets guests’ expectations. She joins QTbreasthealth after spending a year with QT Ultrasound, the privately held technology company that owns and operates QTbreasthealth.

Ms. Johnson holds a number of certifications and licenses from the American Registry of Radiologic Technologists, including the Registered Technologist designation and others in Radiography, Computed Tomography and Magnetic Resonance Imaging.

A native Texan, Ms. Johnson completed all her education and training in the Lonestar State. She holds a bachelor's degree in psychology and a master's degree in health administration from Texas A&M, an associate degree in radiologic technology from Blinn College, and a certificate in magnetic resonance imaging from Galveston College.

Robin Terry
BIOMEDICAL ENGINEER
Robin Terry
BIOMEDICAL ENGINEER

As QTbreasthealth's Biomedical Engineer, Robin Terry is responsible for ensuring the quality of the scan images so that each woman receives a clear picture of her breast health. Ms. Terry has played a critical role at QT Ultrasound for several years, helping to create key processes and protocol for testing, developing and reviewing the scanning technology to continuously improve clarity and consistency of the images. She holds a Master of Science and a Bachelor's degree in Biomedical Science from Texas A&M University.

The Leadership Behind the Technology at QT Ultrasound

John C. Klock, M.D.
CEO, MANAGING DIRECTOR AND MANAGER
John C. Klock, M.D.
CEO, MANAGING DIRECTOR AND MANAGER

Dr. Klock is Chief Executive Officer of QT Ultrasound and Managing Director, Manager, and Founder. Prior to QT Ultrasound, Dr. Klock was involved in the start-up of five medical companies, including Co-Founder and President of BioMarin Pharmaceutical, which successfully commercialized five FDA approved drugs; Scientific Founder and Vice President of Research of Glycomed, now Ligand Pharmaceutical; and founding investor in Ultragenyx Pharmaceutical. He also personally brought to market a novel cancer treatment, the first rapid AIDS test, comprehensive tests for detecting metabolic diseases in children, and several drugs for treating pediatric genetic conditions. Dr. Klock has authored over 70 peer-reviewed medical and scientific publications, and eight granted patents.

Rajni Natesan, MD, MBA
CHIEF MEDICAL OFFICER
Rajni Natesan, MD, MBA
CHIEF MEDICAL OFFICER

Dr. Natesan is a board-certified radiologist who brings together years of experience in finance and healthcare. Prior to joining QT Ultrasound, Dr. Natesan led multiple mergers, acquisitions, and financing deals in the medical device, biotech, and pharmaceutical industries, as an investment banker in Lehman Brothers’ Healthcare Group. Dr. Natesan has also served as an Assistant Professor of Diagnostic Radiology at the UT-MD Anderson Cancer Center, and has contributed to multiple publications, national presentations, and grant-funded research in imaging economics.

Mark W. Lenox, Ph.D
CHIEF TECHNOLOGY OFFICER
Mark W. Lenox, Ph.D
CHIEF TECHNOLOGY OFFICER

Dr. Lenox is an electrical and computer engineer with many years of research and development and product development experience in medical imaging. Prior to joining the Company, he was director of medical imaging at the Texas Institute for Preclinical Studies and a Professor of Biomedical Engineering at Texas A & M University. Prior to his academic work, he was director of New Product Development at CTI-PET Systems, manufacturer of the first commercial PET and PET-CT scanners. Dr. Lenox is author of over 70 publications and ten patents.

Ronald T. LoVetri, M.S.
CHIEF OPERATING OFFICER
Ronald T. LoVetri, M.S.
CHIEF OPERATING OFFICER

Mr. LoVetri has experience in manufacturing, software, and IT with industry leaders such as GE, Autodesk, Charles Schwab and BioRad Laboratories.  He has an MS in Engineering and proven leadership in enterprise management and bringing products to market.

Nasser C. Pirshafiey, MBA
CHIEF PRODUCT OFFICER
Nasser C. Pirshafiey, MBA
CHIEF PRODUCT OFFICER

For over three decades Mr. Pirshafiey has developed products and businesses for domestic and multinational firms. Mr. Pirshafiey’s creativity, innovative problem-solving skills, and entrepreneurial mindset have provided professional, technical, and business solutions to many start-ups and mature companies.  He has previously founded and managed two companies with the mission to provide sustainable practices to industries such as medical devices, automotive, aerospace, high-tech, consumer products, and robotics (brief client list: Johnson & Johnson, Siemens, Edwards Life Sciences, Autoliv, TRW).  Mr. Pirshafiey has 16 inventions filed with the US patent office, holds a Bachelor of Science in Aeronautical Engineering, and an MBA with specialization in Entrepreneurship.

Press Releases

QTbreasthealth expands to San Jose

New Center Brings Groundbreaking, Radiation-Free QT Ultrasound Technology to the Region
Read the press release

San Jose, CA – Feb. 28, 2019 – QTbreasthealth, an innovation-driven, patient-friendly breast imaging center designed to provide women with reliable, radiation-free imaging, has opened a new center in San Jose. The new location, at 2512 Samaritan Court, Suite K, is now open and booking appointments.

Due to popular demand for its groundbreaking quantitative transmission ultrasound technology known as the QTscan™, QTbreasthealth is in steady growth mode. The San Jose location is the fourth center to open in only seven months. Other locations include Walnut Creek and Novato, California and Grand Rapids, Michigan. Additional locations are planned to open around the country throughout 2019.

As with all QTbreasthealth centers, the San Jose location features the new FDA-cleared, radiation-free, 3D ultrasound breast imaging technology that requires no compression and no injections.

Ongoing clinical trials and published research have found the QTscan to be successful in identifying various types of breast tissue, particularly within dense breasts. Because QTscan technology provides unimpeded visibility for women with dense breast tissue, it is a logical next step for women who have had a mammogram, but have been notified that they have dense breasts. More than 50% of women between 40 and 50 have dense breasts, which have less fat and more connective, fibrous and glandular tissue compared to lower-density breast tissue.  Because of higher concentration of glandular tissue, women with dense breasts have higher rates of breast cancer.

QTbreasthealth’s goal is to provide technology that enables women to get scanned as often as necessary, with no risk. San Jose was selected as the new location largely due to the region being labeled an “area of concern” by the California Breast Cancer Mapping Project due to significantly higher rates of breast cancer than the majority of the state.

“The QTscan has the clarity to see what other methods can miss, and our centers provide a comfortable, compassionate setting when women need it the most,” said Dotty Bollinger, QTbreasthealth’s Chief Growth Officer. “We’re excited to bring this game-changing technology to the people of San Jose, providing next-generation breast imaging to more women than ever.”

QTbreasthealth offers a spa-like breast imaging experience, complete with soothing scents, comforting robes, and a relaxing imaging scan that some women actually sleep through. Because the QTscan uses no radiation, the exam is available to women of all ages and avoids the frequency limits associated with radiation-based imaging tests. The clear and comprehensive, 3D image delivered by the QTscan makes QTbreasthealth an ideal second opinion for breast imaging, providing a more detailed image than mammography or handheld ultrasound.

Women interested in scheduling an appointment can do so conveniently online at QTbreathealth.com or by calling (408) 217-1352.

About QTbreasthealth:

With three locations in California and one in Michigan, QTbreasthealth, a wholly-owned subsidiary of QT Ultrasound®, is a breast imaging center offering reassurance without radiation. The center’s FDA-cleared QTscan provides clarity into existing areas of concern previously identified, in a comfortable and soothing setting, with no radiation compression or injections. The QT Ultrasound Breast Scanner is for use as an ultrasonic imaging system to provide reflection-mode and transmission-mode images of a patient’s breast. The device is not intended to be used as a replacement for screening mammography.

For more information on the technology behind the QTscan, please visit qtultrasound.com. For more information on QTbreasthealth or to schedule an appointment, please visitqtbreasthealth.com or call 877-478-7226.

Media Contact:

For more information, to arrange interviews or receive visuals, please contact

Paul Williams, paul@medialinecommunications.com, 310/569-0023

 

Breast Imaging Center to Open in Novato with Radiation-free QTscan

QTbreasthealth to open to the public August 20
Read the press release

NOVATO, Calif. August 13, 2018 QTbreasthealth, a breast imaging center designed to give women a comfortable experience and radiation-free imaging, will open its doors to the public on Monday, August 20 at 3 Hamilton Landing, Suite 180A in Novato.

The foundation of the center’s innovative approach is the QTscan – an emerging new trend in ultrasound 3D breast imaging that has no radiation, no compression and no injections. QTscan is currently the only true 3D, FDA-cleared breast imaging technology for women as a follow-up to mammography.

“For every one woman with cancer, there are 19 more who will endure the trauma of a false positive,” said Mark Lenox, Ph.D., Chief Technology Officer of QT Ultrasound, the privately held technology company that owns and operates QTbreasthealth. “Our QTscan provides reassurance without radiation, particularly for women with dense breasts and implants, as a secondary screen to determine the presence of breast mass types.”

The clear and more complete image delivered by the QTscan makes QTbreasthealth the perfect second opinion for breast imaging and a more detailed image than mammography or handheld ultrasound.

The center opens after QT Ultrasound’s ongoing clinical trials found the transmission ultrasound technology used in the QTscan to be successful in identifying various types of breast tissue, particularly within dense breasts. In 2016, the National Institutes of Health (NIH) awarded the company $16 million in funding, which was used to translate and optimize a pre-clinical prototype into the patient-friendly device QTbreasthealth will now offer in its center.

At $600 per scan, QTbreasthealth provides an affordable breast imaging option for most women in a soothing, comfortable and compassionate setting. Women interested in an appointment can conveniently schedule their visit online at the QTbreasthealth website.

Unlike at other breast imaging centers, a patient will receive results via phone or teleconference with a board-certified physician within just 72 hours. Because the QTscan uses no radiation, the exam is available to adults of all ages and avoids the frequency limits associated with radiation-based imaging tests.

“Women deserve a better breast imaging experience,” Lenox said. “We have transformed what has historically been an uncomfortable experience that resulted in worry and unanswered questions into something pleasant and painless that can alleviate concerns and unfounded fear.”

For more information on QTbreasthealth and the QTscan, visit qtbreasthealth.com.

Media Contact:
Josh Hall, Sage & Sterling Communications
Phone: 813-884-9333
Email: josh@sageandsterling.com

About QTbreasthealth
Headquartered in Novato, California, QTbreasthealth is a breast imaging center offering reassurance without radiation. The center’s QTscan provides clarity into existing areas of concern previously identified, in a comfortable and soothing setting. The only true 3D, FDA-cleared breast imaging technology for women as a follow-up to mammography, the QTscan has no associated radiation, compression or injections. QTbreasthealth’s goal is to provide a safe, painless option for breast imaging that will help give women knowledge about their breast health by providing a clear image.

For more information on the QTscan and QT Ultrasound, please visit qtultrasound.com

FDA clearance granted to QT Ultrasound for new breast imaging device

Transmission ultrasound technology provides 360-degree images and a new level of clarity for breast scans, without breast compression.
Read the press release

Novato, CA – June 14, 2017 –

QT Ultrasound LLC has received 510(k) marketing clearance from the U.S. Food and Drug Administration to market its Transmission Wave Ultrasound breast scanner. The company’s Transmission Ultrasound technology generates high fidelity 360° images of the breast with excellent image clarity. The elimination of radiation and breast compression make the QT scan™ an important additional breast imaging tool for physicians and the women they treat; at this time it is not intended as a replacement for screening mammography.

John Klock, M.D., founder and CEO of QT Ultrasound explains that the company’s recent publications have shown that Transmission Ultrasound technology is especially useful in seeing breast anatomy.

The company has initiated a broad-ranging clinical trial program designed to evaluate whether Transmission Ultrasound technology can (1) aid in the reduction of call-back and false-positive biopsy rates; and (2) replace screening mammography. “Our clinical trials are progressing to help us answer these important questions and learn how this new technology can make a difference in women’s health,” added Dr. Klock.

About QT Ultrasound

QT Ultrasound is a privately held company engaged in the research, development, and commercialization of transmission ultrasound technology. Their research has been supported by over $16 million in funding from the Cancer Imaging Program of the National Cancer Institute of the US National Institutes of Health.  The company’s clinical trials have been conducted at many prestigious institutions in the US and Europe and it is currently enrolling women in trials at the Marin Breast Health Trial Center in Novato, California.

Clinical Research

Read more about various studies for QT Ultrasound technology.

3D QTscan image of mass in dense breast